Skip to main content
. 2001 Jun 1;533(Pt 2):315–327. doi: 10.1111/j.1469-7793.2001.0315a.x

Figure 5. Characterization of Kv1.1 cloned from canine colon tissue.

Figure 5

A, representative currents recorded from an oocyte injected with cRNA encoding Kv1.1. Currents were evoked by 400 ms voltage steps from a holding potential of -80 mV to test potentials ranging from -80 to +50 mV, followed by a step to -40 mV to measure tail currents. B, normalized Kv1.1 tail currents at -40 mV following 400 ms step to test potentials ranging from -80 to +50 mV were fitted with a Boltzmann function (V1/2= -25.0 mV, k = 7.7 mV, n = 5). C, voltage dependence of inactivation of Kv1.1 current was measured using 15.5 s conditioning pulses from -70 to +20 mV followed by a step to +40 mV. Normalized test currents were plotted as a function of conditioning pulse potential and fitted with a Boltzmann function (V1/2= -44.8 mV, k = 4.4 mV, n = 6). D, dose-response relationship for DTX-K was plotted at steady-state block. The IC50 was 0.34 nm for DTX-K (n = 5). The inset shows illustrative Kv1.1 currents evoked by 400 ms voltage steps from a holding potential of -80 mV to 0 mV in the absence (○) and presence (⋄) of 1 nm DTX-K.